Population pharmacokinetics and pharmacodynamics of once- and twice-daily rivaroxaban for the prevention of venous thromboembolism in patients undergoing total hip replacement.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples